Ofev Maintains Effectiveness in Advanced IPF Patients, Real-world Study Shows
Ofev (nintedanib) shows a similar ability to reduce lung function decline in patients with advanced idiopathic pulmonary fibrosis (IPF) as those with milder ... Read more
Updates
-
-
The Benefits of Doing Pulmonary Rehab Online
One of my goals as a pulmonary fibrosis patient is to stay as healthy as possible for as long as possible. Regularly exercising has ... Read more -
Ouabain Treatment Reduces Idiopathic Pulmonary Fibrosis Symptoms in Mice
A plant-derived compound called ouabain is a potential treatment for idiopathic pulmonary fibrosis (IPF), according to a recent study. Treatment with ouabain — more ... Read more -
Saying ‘I’m Sick’ Could Mean Many Things. Here’s Why
Lately, I have been taking what feels like an excessive number of sick days, both from work and from day-to-day activities. In the past ... Read more -
Poor Lung Function Before Starting Ofev Seen as Main Reason for Halting Use in UK Real-world Study
A greater decline in lung function prior to treatment start may lead idiopathic pulmonary fibrosis (IPF) patients to stop using Ofev (nintedanib), ... Read more
-
Ofev Maintains Effectiveness in Advanced IPF Patients, Real-world Study Shows
Ofev (nintedanib) shows a similar ability to reduce lung function decline in patients with advanced ... -
The Benefits of Doing Pulmonary Rehab Online
One of my goals as a pulmonary fibrosis patient is to stay as healthy ... -
Ouabain Treatment Reduces Idiopathic Pulmonary Fibrosis Symptoms in Mice
A plant-derived compound called ouabain is a potential treatment for idiopathic pulmonary fibrosis (IPF), according ... -
Saying ‘I’m Sick’ Could Mean Many Things. Here’s Why
Lately, I have been taking what feels like an excessive number of sick days, ... -
Poor Lung Function Before Starting Ofev Seen as Main Reason for Halting Use in UK Real-world Study
A greater decline in lung function prior to treatment start may lead idiopathic pulmonary ... -
Early Phase 2 Data Support Testing GKT831 in IPF, Continuing Work with Other Fibrotic Diseases
Genkyotex’s anti-fibrotic candidate GKT831 appears to be safe and hold therapeutic activity in an ongoing ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Aloperine May Protect Against Pulmonary Fibrosis in Mouse Model, Study Suggests
News Treatment with plant-derived aloperine reduces the severity of lung injury in a mouse model of pulmonary fibrosis, a new Chinese study reports. The research, “Aloperine Protects Mice against Bleomycin-induced Pulmonary Fibrosis by Attenuating Fibroblast Proliferation and Differentiation,” was published ... Read more